Matthew Kapusta

Matthew Kapusta is an experienced executive in the healthcare and biotechnology sectors, currently serving as Chief Executive Officer and Chief Financial Officer at uniQure since December 2014, and as a Board Member at Genezen and the Alliance of Regenerative Medicine since October 2023 and July 2024, respectively. Previous roles include Board Member at Decibel Therapeutics until September 2023, Senior Vice President of Business Development at AngioDynamics from September 2011 to January 2015, and Vice President of Global Financial Planning, Analysis and Strategy at Smith & Nephew from 2009 to 2011. Matthew's investment banking experience includes positions as Managing Director at Collins Stewart and Vice President at both Wells Fargo Securities and Robertson Stephens LLC. Matthew holds an MBA in Finance and Business Management from NYU Stern School of Business and a BBA in Finance and Accounting from the University of Michigan.